The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B viruses

Journal of Clinical Virology

Volumn 58, Issue 1, 2013, Pages 94-99

  Deng, Yi Mo ^a   Iannello, Pina ^a   Caldwell, Natalie ^a   Jelley, Lauren ^a   Komadina, Naomi ^a   Baas, Chantal ^a   Kelso, Anne ^a   Barr, Ian G ^a,b  

^a WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^b UNIVERSITY OF BALLARAT   (Australia)

Author keywords

B lineages; Influenza B; Pyrosequencing; Real time RT PCR

Indexed keywords

HEMAGGLUTININ;

AMPLICON; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; HEMAGGLUTINATION; HUMAN; HUMAN CELL; INFLUENZA B; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL GENETICS; VIROGENESIS; VIRUS ISOLATION;

EID: 84881556996     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.04.018     Document Type: Article

References (14)

1. Ambrose C.S., Levin M.J. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012, 8:81-88.
2. Barr I.G., Jelley L.L. The coming era of quadrivalent human influenza vaccines: who will benefit. Drugs 2012, 72:2177-2185.
3. [accessed 03.12.12]. http://www.cnic.org.cn/uploadfile/2010/0119/20100119111613415.pdf.
4. Rota P.A., Wallis T.R., Harmon M.W., Kendal A.P., Rota J.S., Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990, 175:59-68.
5. Barr I.G., Komadina N., Durrant C., Sjogren H., Hurt A.C., Shaw R.P. Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since. Commun Dis Intell 2000, 2006(30):350-357.
6. Bodewes R., Kreijtz J.H., Geelhoed-Mieras M.M., van Amerongen G., Verburgh R.J., van Trierum S.E., et al. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J Virol 2011, 85:2695-2702.
7. Biere B., Bauer B., Schweiger B. Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol 2010, 48:1425-1427.
8. Zhang N., Fang S., Wang T., Li J., Cheng X., Zhao C., et al. Applicability of a sensitive duplex real-time PCR assay for identifying B/Yamagata and B/Victoria lineages of influenza virus from clinical specimens. Appl Microbiol Biotechnol 2012, 93:797-805.
9. Sheu T.G., Deyde V.M., Garten R.J., Klimov A.I., Gubareva L.V. Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing. Antiviral Res 2010, 85:354-360.
10. Dankbar D.M., Dawson E.D., Mehlmann M., Moore C.L., Smagala J.A., Shaw M.W., et al. Diagnostic microarray for influenza B viruses. Anal Chem 2007, 79:2084-2090.
11. Deng Y.M., Caldwell N., Barr I.G. Rapid detection and subtyping of human influenza A viruses and reassortants by pyrosequencing. PLoS ONE 2011, 6(8):e23400.
12. World Health Organization Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. Wkly Epidemiol Rec 2012, 87:389-400.
13. World Health Organization Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season. Wkly Epidemiol Rec 2013, 88:101-116.
14. Daum L.T., Canas L.C., Arulanandam B.P., Niemeyer D., Valdes J.J., Chambers J.P. Real-time RT-PCR assays for type and subtype detection of influenza A and B viruses. Influenza Other Respi Viruses 2007, 1:167-175.